Glypican-3 vaccine as an adjuvant therapy for hepatocellular carcinoma patients can prolong their overall survival

被引：0
|
作者：
Taniguchi, Masatake [1 ]
Sawada, Yu [2 ]
Yoshikawa, Toshiaki [2 ]
Mizuno, Shoichi [2 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] Kumamoto Univ, Grad Sch, Dept Med Oncol & Translat Res, Div Canc Immunotherapy,Natl Canc Ctr, Kumamoto, Japan
[2] Kumamoto Univ, Natl Canc Ctr, Div Canc Immunotherapy, Kumamoto, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3205
引用
收藏
页码：1333 / 1333
页数：1
相关论文
共 50 条
  • [21] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [22] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Zhen Wang
    Yan-Jiang Han
    Shun Huang
    Meng Wang
    Wen-Lan Zhou
    Hong-Sheng Li
    Quan-Shi Wang
    Hu-Bing Wu
    Amino Acids, 2018, 50 : 309 - 320
  • [23] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (04) : 361 - 366
  • [24] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [25] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [26] DEVELOPMENT AND VALIDATION OF AN SCFV SPECIFIC FOR HUMAN GLYPICAN-3 FOR THERAPY OF HEPATOCELLULAR CARCINOMA
    Li, Yonghai
    Zhao, Aizhi
    Li, Hong
    Adeyemo, Oluwasayo
    Elkin, Daniel
    Scholler, Nathalie
    Kaplan, David E.
    HEPATOLOGY, 2009, 50 (04) : 1135A - 1135A
  • [27] NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA
    Song, Ken
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 10 - 10
  • [28] Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma
    Li, Gary
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Salvador, Katrina
    Richardson, Samantha
    Guest, Matt
    Noncovich, Alain
    Bhat, Abhijit
    Han, Guangzhou
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients
    Li, B.
    Liu, H.
    Shang, H. W.
    Li, P.
    Li, N.
    Ding, H. G.
    AFRICAN HEALTH SCIENCES, 2013, 13 (03) : 703 - 709
  • [30] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
12345